• Episode 528: Investing in Biotech: Nordicus Partners CEO on Life Science Investment Opportunities

  • Dec 27 2024
  • Length: 8 mins
  • Podcast

Episode 528: Investing in Biotech: Nordicus Partners CEO on Life Science Investment Opportunities

Listen for free

View show details

  • Summary

  • Discover how this Nordic-US investment accelerator is transforming early-stage life sciences companies and creating unique opportunities in multibillion-dollar markets.

    In this exclusive interview, Henrik Rouf, CEO of Nordicus Partners (OTCQB: NORD), discusses the company's unique approach to accelerating Nordic life sciences companies into the US market. With decades of combined experience, their team identifies and develops promising biotech opportunities, focusing on treatments for diseases with significant unmet medical needs. Henrik shares insights on their current portfolio companies, Orocidin and Bio-Convert ApS, their strategic position bridging Nordic innovation with US market opportunities, and their debt-free growth strategy.

    Learn more about Nordicus Partners: https://nordicuspartners.com/

    Watch the full YouTube interview here: https://youtu.be/98BfFBNOgmo
    And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Episode 528: Investing in Biotech: Nordicus Partners CEO on Life Science Investment Opportunities

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available